Articles
 |
4 Reasons AbbVie Could Crush the Market Over the Next Decade Dividend Sensei, Seeking Alpha, 05.30.2018 |
 |
21% of ABBV Shareholders Want To Know How Drug Pricing Is Integrated Into Incentive Programs Value Walk, 05.04.2018 |
|
Dividend Aristocrats In Focus Part 45 Bob Ciura, Sure Dividend, 11.21.2017 |
|
Better Dividend Stock: AbbVie or Gilead? Bob Ciura, Sure Dividend, 04.16.2017 |
|
Better Dividend Stock: Abbott Labs or AbbVie? Bob Ciura, Sure Dividend, 01.31.2017 |
Primary Documents
 |
2018 Q1 Earnings Release |
 |
2017 Annual Report and 2018 Proxy Statement |
|
2018 JP Morgan Healthcare Conference Presentation |
 |
Investor Relations |
Also see GF posts tagged $ABBV.
Econ4All 